# Jiang Zhang

> Jiang Zhang is a Series B investor at Ping An Ventures backing Biotechnology and FinTech. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Ping An Ventures](https://shizune.co/investors/profile/ping-an-ventures)
- Total investments: 3
- Last investment: Feb 2016
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jiangz/

Jiang Zhang is a Series B investor at Ping An Ventures focused on Biotechnology and FinTech. Jiang Zhang is the CEO at Ping An Ventures. He attended INSEAD.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| FinTech | 1 | 33% |
| Finance | 1 | 33% |
| Medical | 1 | 33% |
| Health Care | 1 | 33% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 33% |
| Series D | 1 | 33% |
| Funding Round | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 67% |
| Israel | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Rani Therapeutics | Rani is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics, which we believe will have the potential to transform medicine and improve patient outcomes. We have developed the RaniPill capsule, which is our novel, proprietary and patented platform technology, intended to replacesubcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” capsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine. To date, we have successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using the RaniPill capsule. Our development efforts have enabled us to construct an extensive intellectual property portfolio that we believe provides us a competitive advantage. |  |  | Feb 27, 2016 |  |
| Ativa Medical | Ativa Medical is a medical device manufacturing company that is working to make diagnostic test results available in moments, rather than hours and days. The company specializes in the fields of medical device development, point of care diagnostics, microfluidics, and hematology.The company was founded in 2008 and headquartered in Saint Paul,Minnesota. | $15M | Series B | Sep 17, 2015 |  |
| eToro | EToro is a social trading and investment network that allows users to trade currencies, commodities, indices, crypto assets, and stocks. It is a multi-asset investment platform that empowers people to grow their knowledge and wealth as part of a global community. | $27M | Series D | Nov 26, 2014 |  |

3 of 3 investments shown.

## Co-investors
- [Diamond Biofund Inc.](https://shizune.co/investors/profile/diamond-biofund) — VC Fund, 1 deal together
- [Fort Ross Ventures](https://shizune.co/investors/profile/fortross-ventures) — VC Fund, 1 deal together
- [GF Venture Capital](https://shizune.co/investors/profile/gf-venture-capital) — VC Fund, 1 deal together
- [Hermed Capital](https://shizune.co/investors/profile/hermed-capital) — VC Fund, 1 deal together
- [LabCorp](https://shizune.co/investors/profile/laboratory-corporation-of-america) — VC Fund, 1 deal together
- [SBT Venture Capital](https://shizune.co/investors/profile/sbt-venture-capital-4da3) — VC Fund, 1 deal together

## About Ping An Ventures

VC Fund · Pudong, China

Ping An Ventures is a professional VC under Ping An Insurance (Group) Company of China, Ltd. with focused interest in start-ups of emerging innovation. It is committed to growing with the partners and driving success by provision of both funds and managerial expertise, resources and a platform."

2 contacts available at Ping An Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Jiang Zhang | CEO | https://shizune.co/investors/profile/jiang-zhang |
| Hui Zhou | Partner | https://shizune.co/investors/profile/hui-zhou-1391 |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Jiang Zhang invest in?

Jiang Zhang invests primarily in Biotechnology, FinTech and Finance startups, most often at Series B and Series D stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jiang Zhang last invest?

The most recent investment recorded for Jiang Zhang closed in Feb 2016. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co